Product image of Vistide 375mg/5ml (Cidofovir USP) 375mg/ 5ml Vials supplied by GNH India

Vistide 375mg/5ml

Active Ingredient:
Cidofovir USP
Form:
Vials
Brand:
Vistide
Origin:
USA

Vistide 375mg/5ml (Cidofovir USP Vials) 375mg/ 5ml

Vistide 375mg/5ml (Cidofovir USP) is an antiviral medication supplied in vials for injection. This broad-spectrum agent is used to treat serious viral infections. Store at ambient temperature and follow handling guidelines closely.

Strength

375mg/ 5ml

Pack Size

1s

Storage

Ambient

Manufacturer / TM Owner

AVET PHARMACEUTICALS INC

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Cidofovir USP, the active ingredient in Vistide 375mg/5ml, is indicated for the treatment of cytomegalovirus retinitis in immunocompromised patients. It may also be used off-label for other severe viral infections under medical supervision. This medication works by inhibiting viral DNA synthesis. Patients often ask, what is cidofovir used for and how does it help manage viral conditions.

Side Effects

  • Vistide 375mg/5ml may help reduce viral load and slow the progression of infections when administered as directed. Common effects include changes in kidney function, which are typically monitored during therapy. Some patients report fatigue or nausea after treatment. Individual responses vary based on health status and concurrent medications.

Precautions & Warnings

  • Handle Vistide 375mg/5ml vials with care, avoiding direct contact with skin or mucous membranes. Use protective gloves and dispose of materials according to biohazard protocols. Keep vials at ambient temperature and protect from light. Always follow healthcare provider instructions for preparation and administration.

Avoid Interactions

  • Cidofovir USP may interact with other medications affecting kidney function, such as certain antibiotics or diuretics. Combining it with probenecid is common to mitigate renal toxicity. Alcohol and other nephrotoxic drugs should be avoided during therapy. Always disclose all medications to your healthcare provider before starting cidofovir.

Frequently Asked Questions

Cidofovir USP is primarily used to treat cytomegalovirus retinitis in immunocompromised patients.

Vistide is administered via intravenous injection by a healthcare professional.

Common effects include changes in kidney function, fatigue, and nausea.

Cidofovir USP is available by prescription only and should be obtained through licensed pharmacies.

Safety during pregnancy has not been established; consult a healthcare provider for guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cidofovir USP

Cidofovir 375

Cidofovir 375

375mg/5ml Vials
Cidofovir 375.

Cidofovir 375.

375mg/5ml Vials

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT